1. Dashboard

Pfizer NYSE: PFE

Invest Fact Sheet

Pfizer is a research-based global biopharmaceutical company. Its global portfolio includes medicines and vaccines

Name Pfizer
Ticker PFE
Exchange NYSE
Sector Health Care
Industry Drug Manufacturers - Diversified
Price
52W Low/High 		37.60
32.04 / 42.56
Momentum Weak Up
Market cap 209 B
1Y Total Return 14.55%
Weak
1Y Volatility 26.14%
Low Risk
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions

Pfizer is a research-based global biopharmaceutical company. Its global portfolio includes medicines and vaccines

Details

Ticker PFE
Name Pfizer
ISIN US7170811035
CUSIP 717081103
Exchange NYSE
Sector Health Care
Industry Drug Manufacturers - Diversified
Country USA
Currency U.S. Dollar

Share as of 4/15/21

Close Price 37.60
52W Low/High 32.04 / 42.56
Market cap 209 B
1Y Total Return 14.55%
Weak
1Y Volatility 26.14%
Low Risk
Beta 0.34
PE (trailing) 21.99
Below Average
12M Dividends 3.49
Last Dividend Date 1/28/21
Dividend Yield 9.28%

Fin. Strength

Net Profit Margin 22.9%
Cash from Op. / Cur. Liabilities 0.56
Diluted Earnings / Share 1.71
ROE 15.2%
ROIC 7.7%
Price / Revenue 5.1
Price / Book 3.3
Price / CF 14.7
Current Ratio 1.4
Cur.Liabilities / Tot.Liabilities 0.3
Financial Leverage 0.63
in Mils USD
rolling-year up to December
 
Income Statement 2020 2019 2018 2017 2016 2015  
Revenue
41,908
41,172
40,825
52,546
52,824
48,851
Gross Profit
33,216
32,921
31,838
41,318
40,502
39,203
R&D
9,405
8,394
7,760
7,683
7,892
7,690
EBITDA
14,870
22,686
17,036
18,528
14,095
14,107
Operating Income
7,491
3,400
3,595
12,306
8,351
8,964
Net Income exc. Extra
9,616
16,273
11,152
21,308
7,215
6,960
per Share  
Diluted avg Shares
5,632
5,675
5,977
6,058
6,159
6,257
EPS exc. Extra
1.71
2.87
1.87
3.52
1.17
1.11
Dividend
3.49
1.44
1.36
1.28
1.20
1.12
  
Div. Yield (an.)
9.48%
3.68%
3.12%
3.53%
3.69%
3.47%
  
Balance Sheet 2020 2019 2018 2017 2016 2015  
Total Assets
154,229
167,594
159,422
171,797
171,615
167,381
Cash, Eq & Invt ShortTerm
12,221
9,646
18,833
19,992
17,850
23,290
Total Current Assets
35,067
32,803
49,926
41,141
38,949
43,804
Total Non-Current Assets
119,162
134,791
109,496
130,656
132,666
123,577
Intangibles
78,048
82,138
88,622
104,693
107,097
88,598
Total Liabilities
90,756
104,148
95,664
100,141
111,776
102,384
Total Current Liabilities
25,920
37,304
31,858
30,427
31,115
29,399
Long Term Debt
64,836
66,844
63,806
69,714
80,661
72,985
Shareholder equity
63,238
63,143
63,407
71,308
59,544
64,720
Cash Flow 2020 2019 2018 2017 2016 2015  
Cash from Operations
14,403
12,588
15,827
16,802
16,192
14,688
Depreciation
4,777
5,795
6,150
6,269
5,757
5,157
Cash from Investing
-4,271
-3,945
4,525
-4,740
-7,791
-2,980
Capex
2,791
2,490
2,136
2,217
1,999
1,496
Cash from Financing
-9,649
-8,485
-20,441
-13,350
-9,228
-10,409
Stock Issued
425
-8,471
-10,939
-4,138
-3,981
-4,897
Debt (LT) Issued
-12,755
8,764
-935
-941
2,606
1,319
Free Cash Flow
-1,873
26,307
19,177
28,192
12,652
17,495
Ratios 2020 2019 2018 2017 2016 2015  
Net Profit Margin
22.9%
39.5%
27.3%
40.6%
13.7%
14.2%
  
NCFO / Op.Income
192.3%
370.2%
440.3%
136.5%
193.9%
163.9%
  
Current Ratio
1.4
0.9
1.6
1.4
1.3
1.5
  
Financial Leverage D/E
0.63
0.83
0.66
0.61
0.71
0.60
  
Return on Capital Avg
7.7%
12.5%
8.3%
18.4%
5.4%
5.4%
  
Return on Shareholder Equity
15.2%
25.7%
16.6%
32.6%
11.6%
10.2%
  

Data

Fundamentals

More Info

No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available